Adlai Nortye (NASDAQ:ANL) Releases Earnings Results, Beats Expectations By $0.07 EPS

Adlai Nortye (NASDAQ:ANL) posted its quarterly earnings data on Friday. The company reported ($0.06) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.07, FiscalAI reports. The firm had revenue of $6.53 million during the quarter, compared to analyst estimates of $4.72 million.

Adlai Nortye Stock Performance

NASDAQ:ANL traded up $0.39 on Friday, hitting $13.25. 56,285 shares of the stock were exchanged, compared to its average volume of 410,120. The stock has a fifty day moving average of $11.37 and a 200-day moving average of $10.75. Adlai Nortye has a fifty-two week low of $0.88 and a fifty-two week high of $17.25.

Analysts Set New Price Targets

Several analysts have commented on ANL shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Adlai Nortye in a research note on Tuesday, July 14th. Cantor Fitzgerald initiated coverage on Adlai Nortye in a report on Monday, June 22nd. They set an “overweight” rating on the stock. JonesTrading assumed coverage on Adlai Nortye in a research report on Thursday, May 14th. They issued a “buy” rating and a $22.00 price objective for the company. HC Wainwright increased their target price on Adlai Nortye from $16.00 to $20.00 and gave the stock a “buy” rating in a research report on Monday, April 20th. Finally, Oppenheimer initiated coverage on Adlai Nortye in a research note on Thursday, May 28th. They issued an “outperform” rating and a $32.00 price target on the stock. Five equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, Adlai Nortye has an average rating of “Moderate Buy” and an average price target of $24.25.

Adlai Nortye Company Profile

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.